Literature DB >> 1828169

Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha.

J W Koper, E C Zwarthoff, A Hagemeijer, R Braakman, C J Avezaat, M Bergström, S W Lamberts.   

Abstract

In this paper the results of investigations on the effect of interferon-alpha (IFN-alpha) on the growth of meningioma cells in culture is reported. A consecutive series of six meningiomas and one meningioma/neurofibroma derived from a patient with neurofibromatosis type 2 was investigated and it was found that the growth of all seven tumours in response to mitotic stimuli (fetal bovine serum or epidermal growth factor) is strongly inhibited by IFN-alpha. Maximal response varied between 100% and 70% inhibition of the incorporation of tritiated thymidine. In some cases an inhibitory response was obtained already at very low doses (less than or equal to 10 U of IFN-alpha per ml). These results indicate that further clinical investigation of the application of IFN-alpha to the treatment of meningioma is warranted.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828169     DOI: 10.1016/0277-5379(91)90375-n

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.

Authors:  F van Valen; W Winkelmann; S Burdach; U Göbel; H Jürgens
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 2.  Multimodality Therapy of Patients with Refractory Meningiomas.

Authors:  Haroon Ahmad; David Schiff
Journal:  Curr Treat Options Oncol       Date:  2019-05-09

Review 3.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

Review 4.  Management options for cavernous sinus meningiomas.

Authors:  Michael T Walsh; William T Couldwell
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 5.  The biology of meningiomas.

Authors:  I E McCutcheon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

Review 6.  Chemotherapy for meningiomas.

Authors:  A P Kyritsis
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

Review 7.  Medical management of meningiomas.

Authors:  Wendy J Sherman; Jeff J Raizer
Journal:  CNS Oncol       Date:  2013-03

8.  IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-05

9.  TGF alpha expression in meningioma--tumor progression and therapeutic response.

Authors:  R M Linggood; D W Hsu; J T Efird; F S Pardo
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

Review 10.  An overview of meningiomas.

Authors:  Robin A Buerki; Craig M Horbinski; Timothy Kruser; Peleg M Horowitz; Charles David James; Rimas V Lukas
Journal:  Future Oncol       Date:  2018-08-07       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.